Abstract:Acceptance sampling plans used in a typical quality control process, are developed to provide optimal sample size(s) and acceptance (rejection) criterion. In order to apply a sampling plan, a knowledge of acceptable quality level (AQL), a lot tolerance percent defective (LTPD), and the specification of two types of errors (type I and type II) are required. The traditional methods assume that quality control inspectors, inspection tools, and computation processes are free from any errors under normal conditions. However, it has been shown that in practice inspectors, inspection tools as well as computation processes are all erroneous. These errors will have significant impact on sample size(s), decision criterion, average outgoing quality (AOQ), and the operating characteristics curve (OC Curve).The impact of imperfect inspection on AOQ, sample size(s), and OC curves for a two stage sampling plan are presented in this paper. In a two stage sampling plan, the decision to reject or accept a lot is made through two tandem stages of the inspection process. The first stage inspection is performed at the low level component, where m components constitute a single item. An acceptance decision for a single item is made based on the observed number of defects (non-conformities), while an acceptance decision of a given lot depends on the number of defective (non-conforming) items.A simulation program has been developed to investigate the sensitivity of AOQ and OC curves when one or both types of errors (type I and type II) deviate from their specified levels. The computational experiments show that inspection errors cause the discrepancies between the computed values and the specified values. The analysis of simulation results leads us to conclude that, when inspection errors are present, the traditional sampling plans without inclusion of inspection errors are misleading and incorrect.

Two-stage sampling in pharmaceutical applications.

[Multistage Multivariate Statistic Quality Control (MMSQC) for Monitoring Production Process of Traditional Chinese Medicines].

Sequential Continual Reassessment Method for Two-Dimensional Dose Finding.

Analysis of two stage sampling plan with imperfect inspection

Application of statistics methodology in pharmaceutical research and development, manufacturing and quality management

A variable-type skip-lot sampling plan for products with a unilateral specification limit

Seamless Phase II/III Design: a Useful Strategy to Reduce the Sample Size for Dose Optimization

Two-Stage Chain Sampling Inspection Plans with Different Sample Sizes in the Two Stages

Optimal designing of two-level skip-lot sampling reinspection plan

Measuring sampling plan utility in post-market surveillance of medical product supply chains

A Broad and General Sequential Sampling Scheme

Adaptive two-stage seamless sequential design for clinical trials

In Vitro Bioequivalence Testing.

Bayesian Approach to Probabilistic Design Space Characterization: A Nested Sampling Strategy

A Novel Sample Selection Strategy by Near-Infrared Spectroscopy-Based High Throughput Tablet Tester for Content Uniformity in Early-Phase Pharmaceutical Product Development.

Optimal Acceptance Sampling Testing Plan With Pivotal Quantity for Log-Location-Scale Distributions

A Method of Sampling Inspection

Sequential Sampling Statistics for Evaluating Low Concentrations

Quality by Design Approach: Progress in Pharmaceutical method Development and Validation

Chain Sampling Inspection Plans Based on Bayesian Methodology

Developing a sampling plan by variables inspection for controlling lot fraction of defectives